EXACOMPTA CLAIREFONTAINE (EPA:EXAC) | WebDisclosure

Basculer en Français

10643	Companies
226374	Keywords
154844	Articles
119814	Press releases

Headlines Articles Press releases EXACOMPTA CLAIREFONTAINE

Home
Companies
EXACOMPTA CLAIREFONTAINE

REGULATED PRESS RELEASE

published on 09/24/2025 at 18:15, 9 months 1 day ago

Rapport semestriel 2025
BRIEF

published on 09/23/2025 at 18:20, 9 months 2 days ago

EXACOMPTA CLAIREFONTAINE Reports Decrease in H1 2025 Profits

Financial Results Market Challenges Revenue Decline Operating Income Management Changes
BRIEF

published on 09/23/2025 at 18:20, 9 months 2 days ago

EXACOMPTA CLAIREFONTAINE annonce une baisse de ses bénéfices au premier semestre 2025

Résultats Financiers Baisse Des Revenus Défis Du Marché Changements De Direction Résultat D'exploitation
REGULATED PRESS RELEASE

published on 09/23/2025 at 18:15, 9 months 2 days ago

Financial statements - 30 june 2025
EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved Group financial statements for H1 2025 in Paris. Revenue down, operating income dropped, economic challenges noted

Financial Statements Revenue Operating Income Exacompta Clairefontaine Economic Conditions
BRIEF

published on 09/18/2025 at 18:20, 9 months 7 days ago

EXACOMPTA CLAIREFONTAINE 2025 half-year report: declining results

Half-year Results Turnover General Management Financial Debt Outlook 2025
BRIEF

published on 09/18/2025 at 18:20, 9 months 7 days ago

Bilan semestriel 2025 d'EXACOMPTA CLAIREFONTAINE : résultats en baisse

Chiffre D'affaires Résultats Semestriels Direction Générale Endettement Financier Perspectives 2025
REGULATED PRESS RELEASE

published on 09/18/2025 at 18:15, 9 months 7 days ago

Rapport semestriel 2025
Le conseil d'administration d'EXACOMPTA CLAIREFONTAINE arrête les comptes du 1er semestre 2025, marquant une baisse des résultats. Changement majeur aux postes de direction

Conseil D'administration Baisse Direction Exacompta Clairefontaine Comptes
REGULATED PRESS RELEASE

published on 05/13/2025 at 18:11, 1 year 1 month ago

DPEF - non financial performance declaration 2024
REGULATED PRESS RELEASE

published on 05/13/2025 at 18:10, 1 year 1 month ago

Annual report 2024
REGULATED PRESS RELEASE

published on 04/28/2025 at 18:10, 1 year 1 month ago

Rapport annuel 2024 - DPEF

Accesswire

Published on 06/26/2026 at 01:40, 8 hours 26 minutes ago

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 10 hours 36 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 11 hours 36 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 12 hours 34 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 18 hours 36 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 09:59, 7 minutes ago

AGRANA finalises sale of Leopoldsdorf areal to PCS Holding
Published on 06/26/2026 at 09:43, 22 minutes ago

ABO Energy secures wind energy tariffs and achieves further successes
Published on 06/26/2026 at 09:41, 24 minutes ago

Emerald Horizon AG begins trading on the Vienna Stock Exchange
Published on 06/26/2026 at 09:26, 40 minutes ago

Hamburg Direct Bank wins two German Brand Awards 2026
Published on 06/26/2026 at 09:25, 41 minutes ago

SKYWORTH Solar Shines at Intersolar Europe 2026, Shaping the Future of Energy in Europe with a Comprehensive Product Matrix

Les Echos

Published on 06/26/2026 at 07:00, 3 hours 6 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 3 hours 6 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 15 hours 21 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 15 hours 36 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 16 hours 16 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE